Literature DB >> 19138987

Kava, a tonic for relieving the irrational development of natural preventive agents.

Rajesh Agarwal1, Gagan Deep.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19138987      PMCID： PMC2675608          DOI： 10.1158/1940-6207.CAPR-08-0172

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN： 1940-6215


× No keyword cloud information.
  32 in total

Review 1.  Silymarin: a review of its clinical properties in the management of hepatic disorders.

Authors:  K Wellington; B Jarvis
Journal:  BioDrugs       Date:  2001       Impact factor: 5.807

2.  The correlation between cancer incidence and kava consumption.

Authors:  G G Steiner
Journal:  Hawaii Med J       Date:  2000-11

Review 3.  Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents.

Authors:  R Agarwal
Journal:  Biochem Pharmacol       Date:  2000-10-15       Impact factor: 5.858

4.  Anticancer action of cubé insecticide: correlation for rotenoid constituents between inhibition of NADH:ubiquinone oxidoreductase and induced ornithine decarboxylase activities.

Authors:  N Fang; J E Casida
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

5.  A flavonoid antioxidant, silymarin, affords exceptionally high protection against tumor promotion in the SENCAR mouse skin tumorigenesis model.

Authors:  M Lahiri-Chatterjee; S K Katiyar; R R Mohan; R Agarwal
Journal:  Cancer Res       Date:  1999-02-01       Impact factor: 12.701

6.  Kava: herbal panacea or liver poison?

Authors:  Robert F W Moulds; Joji Malani
Journal:  Med J Aust       Date:  2003-05-05       Impact factor: 7.738

7.  Cancer incidence in the islands of the Pacific.

Authors:  B E Henderson; L N Kolonel; R Dworsky; D Kerford; E Mori; K Singh; H Thevenot
Journal:  Natl Cancer Inst Monogr       Date:  1985-12

8.  Kava lactones and the kava-kava controversy.

Authors:  Peter A Whitton; Andrew Lau; Alicia Salisbury; Julie Whitehouse; Christine S Evans
Journal:  Phytochemistry       Date:  2003-10       Impact factor: 4.072

Review 9.  Kava: an overview.

Authors:  Y N Singh
Journal:  J Ethnopharmacol       Date:  1992-08       Impact factor: 4.360

10.  Epidermal growth factor receptor mediates silibinin-induced cytotoxicity in a rat glioma cell line.

Authors:  Lin Qi; Rana P Singh; Yingnian Lu; Rajesh Agarwal; Gail S Harrison; Alex Franzusoff; L Michael Glode
Journal:  Cancer Biol Ther       Date:  2003 Sep-Oct       Impact factor: 4.742
View more
  4 in total

1.  Isosilybin A induces apoptosis in human prostate cancer cells via targeting Akt, NF-κB, and androgen receptor signaling.

Authors:  Gagan Deep; Subhash C Gangar; Nicholas H Oberlies; David J Kroll; Rajesh Agarwal
Journal:  Mol Carcinog       Date:  2010-10       Impact factor: 4.784

2.  Inhibition of mitogen activated protein kinases increases the sensitivity of A549 lung cancer cells to the cytotoxicity induced by a kava chalcone analog.

Authors:  Janel K Warmka; Eric L Solberg; Nicholette A Zeliadt; Balasubramanian Srinivasan; Aaron T Charlson; Chengguo Xing; Elizabeth V Wattenberg
Journal:  Biochem Biophys Res Commun       Date:  2012-07-03       Impact factor: 3.575

Review 3.  Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer.

Authors:  Gagan Deep; Rajesh Agarwal
Journal:  Cancer Metastasis Rev       Date:  2010-09       Impact factor: 9.264

4.  Amelioration of an undesired action of deguelin.

Authors:  Julie A Vrana; Nathan Boggs; Holly N Currie; Jonathan Boyd
Journal:  Toxicon       Date:  2013-08-07       Impact factor: 3.033
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.